Gregory Otterson MD in Dublin, Ohio

Home Ohio Dublin

Gregory Otterson MD has Medical Oncology as his primary medical specialty. Their primary office is: 3900 Stoneridge Ln in Dublin, Ohio.

They're a part of the: Osu Internal Medicine Llc medical group which has around 1,002 members. You can call their office at 614-889-5001 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Georgetown University School Of Medicine and graduated in 1986 (around 39 years of experience). They are listed as doing telehealth appointments.

Gregory A Otterson MD Office Phone and Directions

Gregory Otterson MD
Osu Internal Medicine Llc
3900 Stoneridge Ln
Dublin, Ohio 43017
614-889-5001

Patient Ratings
Please rate your experience with Gregory Otterson MD below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 614-889-5001

Enter a starting address:

Healthcare Info for Gregory Otterson MD

Medical School: Georgetown University School Of Medicine
Graduation Year: 1986
The Primary Medical Specialty for Gregory Otterson MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 39
PAC (PECOS ID)#: 9436143120
NPI #: 1215945548
NPI Created On: 08/03/2006
NPI Last Updated Listed as: 12/04/2020
Primary Taxonomy Code: 207RX0202X
License Number:
35.074706
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

MOLINA HEALTHCARE OF OHIO
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $1,800

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783492015

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $5,400

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 823639501

Being Disputed:: No

Product Related: No

Payments Total: $5,550

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 823639503

Being Disputed:: No

Product Related: No

Payments Total: $74

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 813134437

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: MEKINIST

Open Associated Drug #1: 0078-0666-15

Drug or Biological: Drug

Product Category #2: ONCOLOGY

Name Of Drug #2:: TAFINLAR

Associated Drug #2: 0078-0681-66

Drug or Biological #3:: Drug

Product Category #3: ONCOLOGY

Name of Drug: TABRECTA

Name Of Drug #3: 0078-0709-56

Payments Total: $1,950

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 846701789

Being Disputed:: No

Product Related: No

Payments Total: $132

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Context of payment:: Informational Meal

Record ID:: 829443703

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: LYNPARZA

Open Associated Drug #1: 0310-0657-58